One recent study investigated the influence of CD123 expression on clinical outcomes of adult B-ALL, but no correlation was found between CD123 prevalence and leukemia-free survival or overall survival in adult B-ALL patients (23). This evidence concerns the gene IL3RA and precursor B-cell acute lymphoblastic leukemia.